{
  "id": "7ae7221cadd69339",
  "title": "Is Immunovant Stock a Buy After Roivant Sciences Increased Its Stake by $350 Million ? ",
  "description": "20251218T101500Z",
  "content": "",
  "source": "fool.com",
  "source_url": "https://www.fool.com/coverage/filings/2025/12/18/is-immunovant-stock-a-buy-after-roivant-sciences-increased-its-stake-by-usd350-million/?source=iedfolrf0000001",
  "published_at": "20251218T101500Z",
  "fetched_at": "2025-12-19T00:23:08.544189+00:00",
  "category": "health_biotech",
  "subcategory": null,
  "keywords": [],
  "location": "United States",
  "raw_data": {
    "url": "https://www.fool.com/coverage/filings/2025/12/18/is-immunovant-stock-a-buy-after-roivant-sciences-increased-its-stake-by-usd350-million/?source=iedfolrf0000001",
    "url_mobile": "",
    "title": "Is Immunovant Stock a Buy After Roivant Sciences Increased Its Stake by $350 Million ? ",
    "seendate": "20251218T101500Z",
    "socialimage": "https://cdn.content.foolcdn.com/images/1umn9qeh/production/ad04e80951d6de292a5f59f60fce986c74bc8b4f-1401x1251.png",
    "domain": "fool.com",
    "language": "English",
    "sourcecountry": "United States"
  }
}